Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 2/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | MME | P08473 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8695240 | 0.95 | CETP (0.41) | CETPCYP4F2CYP4A11CYP2C19MME | |
| SCHEMBL517348 | 0.93 | CETP (0.43) | CETPCYP4F2CYP4A11CYP2C19MME | |
| Hydrochloric Acid SCHEMBL28065415 | 0.91 | CETP (0.42) | CETPCYP4F2CYP4A11CYP2C19MME | |
| SCHEMBL4201007 | 0.91 | — | — | |
| SCHEMBL12273729 | 0.87 | CETP (0.41) | CETPCYP4F2CYP4A11 | |
| SCHEMBL5038262 | 0.84 | CETP (0.43) | CETPCYP4F2CYP4A11 | |
| SCHEMBL11359161 | 0.83 | CETP (0.44) | CETPCYP4F2CYP4A11CYP2C19 | |
| SCHEMBL1768081 | 0.81 | — | — | |
| SCHEMBL21565394 | 0.81 | KDM4E (0.46) | — | |
| SCHEMBL17447481 | 0.81 | KDM4E (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2504314-A1 | QUINAZOLINE DERIVATIVES | Merck Patent GmbH (DE) | 2012-10-03 | — | — | EP | claimed |
| WO-2011060873-A1 | QUINAZOLINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2011-05-26 | — | — | WO | claimed |
| WO-2024030960-A2 | COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS | Kojin Therapeutics, Inc. (US) | 2024-02-08 | — | — | WO | disclosed |
| WO-2023147531-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-08-03 | — | — | WO | disclosed |